UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Author | Type
Jump to: A | B | C | D | F | G | H | J | L | M | O | P | R | S | T | V | W
Number of items: 101.

A

Arkenau, H-T; Hegglin, I; Luthi, U; Gebbers, J-O; (2000) Trichosporonose. Schweizerische Medizinische Wochenschrift , 130 (49) 1914 - 1914.

Arkenau, H-T; Lüthi, U; (2000) Seifenblasenläsionen. Schweizerische Medizinische Wochenschrift , 130 (51-52) 2017 - 2017. Gold open access

Arkenau, H-T; Luthi, U; Gebbers, J-O; (2000) Amyloidome. Schweizerische Medizinische Wochenschrift , 130 (35) 1244 - 1244.

Arkenau, HT; Hegglin, I; Lüthi, U; (2000) [Trichosporosis]. Schweiz Med Wochenschr , 130 (49) 1914 - ?.

Arkenau, HT; Lüthi, U; (2000) [Amyloidoma]. Schweiz Med Wochenschr , 130 (35) 1244 - ?.

Azzabi, AS; Calvert, AH; Verrill, M; Kelly, C; Lind, MJ; Newell, DR; ... Boddy, AV; + view all (2000) Phase I and pharmacokinetic study of temozolomide and paclitaxel in the treatment of malignant melanoma. Clinical Cancer Research , 6 539 - ?.

B

Baddeley, H; Brodrik, PM; Taylor, NJ; Abdelatti, MO; Jordan, LC; Vasudevan, AS; ... Hoskin, PJ; + view all (2000) Gas exchange parameters in radiotherapy patients during breathing of 2%, 3.5% and 5% carbogen gas mixtures. British Journal of Radiology , 73 (874) 1100 - 1104.

Bentley, J; Arris, CE; Boyle, FT; Calvert, AH; Curtin, NJ; Endicott, JA; ... Newell, DR; + view all (2000) Structure-activity relationships and cellular effects of novel purine- and pyrimidine-based cyclin dependent kinase inhibitors. Clinical Cancer Research , 6 328 - ?.

Bentzen, SM; Hoskin, P; Roos, D; Nielsen, OS; (2000) Fractionated radiotherapy for metastatic bone pain: Evidence- based medicine or ...? International Journal of Radiation Oncology Biology Physics , 46 (3) 681 - 682.

Berardi, R; Strauss, S; Blake, D; Whelan, JS; (2000) Is it safe to substitute oral for intravenous mesna? A case control study. In: ASCO, New Orleans May 2000 Proc ASCO 2000;19: 609.

Bhatia, J; Sharma, SK; Pedley, BR; Boxer, G; Robson, L; Begent, RHJ; Chester, K; (2000) In vitro and in vivo stability of purified MFE 23 :: CPG2 fusion protein from Pichia pastoris. In: British Journal of Cancer. (pp. 170 - 170).

Bhatia, J; Sharma, SK; Pedley, BR; Boxer, G; Robson, L; Begent, RHJ; Chester, KA; (2000) In vitro & in vivo stability of purified MFE 23 :: CPG2 fusion protein from Pichia pastoris. In: British Journal of Cancer. (pp. 71 - 71).

Boddy, AV; Griffin, MJ; Wright, JG; Sludden, JA; Thomas, HD; Fishwick, K; ... Calvert, AH; + view all (2000) Paclitaxel and carboplatin dose-intensity and duration of infusion in the treatment of ovarian cancer. British Journal of Cancer , 83 203 - ?.

Burcombe, RJ; Makris, A; Richman, PI; Daley, F; Noble, S; Wilson, GD; (2000) Persistence of c-erbB-2 overexpression after neoadjuvant chemotherapy for primary breast cancer. British Journal of Cancer , 83 36 - ?.

Burcombe, RJ; Ostler, PJ; Ayoub, AW; Hoskin, PJ; (2000) The role of staging CT scans in the treatment of prostate cancer: A retrospective audit. Clinical Oncology , 12 (1) 32 - 35.

C

Calabrese, CR; Curtin, NJ; Canan-Koch, SS; Batey, MA; Thomas, HD; Kyle, S; ... Newell, DR; + view all (2000) Design and evaluation of novel potent inhibitors of poly(ADP-ribose) polymerase. Clinical Cancer Research , 6 150 - ?.

Calvert, P; Jayson, G; Atkinson, R; Ganesan, T; Cervantes-Ruiperez, A; Vasey, P; ... Cheverton, P; + view all (2000) Phase II clinical and pharmacokinetic study of exatecan mesylate (DX-8951f) in patients with advanced ovarian cancer, refractory to, or relapsed after platinum and taxane. Annals of Oncology , 11 372P - ?.

Calvert, PM; O'Neill, V; Azzabi, A; Hughes, A; Plummer, R; Twelves, C; ... Calvert, AH; + view all (2000) A phase I clinical and pharmacokinetic study of EPO906 (epothilone B) in patients with advanced solid tumours. Clinical Cancer Research , 6 575 - ?.

Casey, JL; Pedley, RB; King, DJ; Boden, R; Chapman, A; Yarranton, GTAB; R, HJ; (2000) Improved tumour targetting of divalent Fab’ fragments modified with polyethylene glycol. Tumor Targeting , 4 235 - 244.

Casey, JL; Pedley, RB; King, DJ; Boden, R; Chapman, AP; Yarranton, GT; Begent, RHJ; (2000) Improved tumour targeting of di-Fab ' fragments modified with polyethylene glycol. Tumor Targeting , 4 (4) 235 - 244.

Chang, J; Powles, TJ; Allred, DC; Ashley, SE; Makris, A; Gregory, RK; ... Dowsett, M; + view all (2000) Prediction of clinical outcome from primary tamosifen by expression of biologic markers in breast cancer patients. Clinical Cancer Research , 6 (2) 616 - 621.

Clingen, PH; Denholm, EE; De Silva, IU; Hockey, A; Hartley, JA; (2000) Response of human DNA repair defective cell lines to DNA interstrand agents. British Journal of Cancer , 83 138 - ?.

Cooke, SP; Boxer, GM; Spencer, DIR; Lawrence, L; Pedley, RB; Chester, KA; Begent, RHJ; (2000) Tumour vascular targeting using a novel anti-vascular endothelial cell growth factor (VEGF) scFv antibody. British Journal of Cancer , 83 14 - ?.

Cooke, SP; Boxer, GM; Spencer, DIR; Lawrence, L; Pedley, RB; Chester, KA; Begent, RHJ; (2000) Tumour vascular targeting using a novel anti-vascular endothelial cell growth factor (VEGF) scFv antibody. British Journal of Cancer , 83 (Suppl) 14 - ?.

Cooooke, SP; Boxer, GM; Spencer, DIR; Lawrence, L; Pedley, RB; Chester, KA; Begent, RHJ; (2000) Tumour vascular targeting using a novel anti-vascular endothelial cell growth factor (VEGF) scFv antibody. In: (Proceedings) British Journal of Cancer. (pp. 14 - 14).

Cunningham, D; Mainwaring, PN; Gregory, W; Hoskin, P; Hancock, B; Smith, P; ... Linch, D; + view all (2000) Mitoxantrone is superior to doxorubicin in a multi-agent weekly regimen for patients with high-grade lymphoma over the age of 60 years: Results of a BNLI randomised trial of PACEBO vs. British Journal of Cancer , 83 (Su 1 - ?.

Curtin, NJ; Calvert, AH; Canan-Koch, S; Durkacz, BW; Griffin, RJ; Golding, BT; ... Yu, XH; + view all (2000) Chemopotentiation studies with two classes of potent (polyADP-ribose) polymerase (PARP) inhibitors in human lung and colon carcinoma cell lines. Clinical Cancer Research , 6 205 - ?.

D

Dearling, JLJ; Flynn, AA; Pagoulatos, C; Wilson, GD; Woodcock, M; Denholm, E; ... Pedley, RB; + view all (2000) Influence of tumour cell response and nuclide selection on the efficacy of RIT. British Journal of Cancer , 83 (Suppl) 173 - ?.

Dearling, JLJ; Flynn, AA; Watson, RJ; Boxer, GM; Sutcliffe-Goulden, J; Boden, R; ... and Pedley, RB; + view all (2000) : Potential for use of [C-14]2DG as a predictor of [F-18]FDG tumour distribution for assessment of therapeutic efficacy. In: Nuclear Medicine Communications. (pp. 394 - 395).

Dey, A; McCloskey, EV; Taube, T; Cox, R; Pande, KC; Ashford, RU; ... Kanis, JA; + view all (2000) Metacarpal morphometry using a semi-automated technique in the assessment of osteoporosis and vertebral fracture risk. Osteoporos Int , 11 (11) 953 - 958.

Di Francesco, AM; Hargreaves, RHJ; Wallace, TW; Mayalarp, SP; Hazrati, A; Hartley, JA; Butler, J; (2000) Anti-tumour properties of novel diaziridinylquinones. British Journal of Cancer , 83 152 - ?.

Di Francesco, AM; Hargreaves, RHJ; Wallace, TW; Mayalarp, SP; Hazrati, A; Hartley, JA; Butler, J; (2000) Anti-tumour properties of novel diaziridinylquinones. Clinical Cancer Research , 6 309 - ?.

Di Francesco, AM; Hargreaves, RHJ; Wallace, TW; Mayalarp, SP; Hazrati, A; Hartley, JA; Butler, J; (2000) Anti-tumour properties of novel diaziridinylquinones. British Journal of Cancer , 83 152 - ?.

Di Francesco, AM; Hargreaves, RHJ; Wallace, TW; Mayalarp, SP; Hazrati, A; Hartley, JA; Butler, J; (2000) Anti-tumour properties of novel diaziridinylquinones. Clinical Cancer Research , 6 309 - ?.

Dunlop, DJ; Connery, L; O, BM; Thatcher, N; Lee, SM; Hill, S; Thatcher, N; (2000) Phase II study of carboplatin and vinorelbine in small cell lung cancer. In: (Proceedings) 2000 ASCO Annual Meeting/36th Annual Meeting, New Orleans, LA.. (pp. 518a - ?). Proceedings of the American Society of Clinical Oncology

Dunlop, DJ; O'Brien, M; Lee, S; Hill, S; Thatcher, N; (2000) Multicentre phase II study of carboplatin (AUC 5) and vinorelbine in small cell lung cancer (SCLC). In: (Proceedings) British Cancer Research Meeting, Brighton.. (pp. 42 - ?). British Journal of Cancer

F

Francis, RJ; Sharma, SK; Sena, L; Springer, C; Green, AJ; Hope-Stone, LD; ... Begent, RHJ; + view all (2000) A phase I trial of antibody directed enzyme prodrug therapy (ADEPT) in patients with advanced colorectal carcinoma or other CEA producing tumours. British Journal of Cancer , 83 (Suppl) 18 - ?.

Francis, RJ; Sharma, SK; Sena, L; Springer, C; Green, AJ; Hope-Stone, LD; ... Begent, RHJ; + view all (2000) A phase I trial of antibody directed enzyme prodrug therapy (ADEPT) in patients with advanced colorectal carcinoma or other CEA producing tumours. British Journal of Cancer , 83 43 - ?.

G

Gorodetsky, R; Lotan, C; Piggot, K; Pierce, L; Polyansky, I; Dische, S; ... Vexler, A; + view all (2000) Late effects of dose fractionation on the mechanical properties of breast skin following post-lumpectomy radiotherapy (vol 45, pg 893, 1999). International Journal of Radiation Oncology Biology Physics , 47 (2) 545 - 545.

Griffin, RJ; Arris, CE; Calvert, AH; Curtin, NJ; Jewsbury, P; Endicott, JA; ... Lawrie, A; + view all (2000) Design, synthesis, and biological evaluation of O-6-alkylguanine and O-4-alkylpyrimidine cyclin-dependent kinase inhibitors. Abstracts of Papers of the American Chemical Society , 219 296 - MEDI.

H

Hampel, C; Tolner, B; Webley, SD; Lam, E; Hartley, JA; Hochhauser, D; (2000) Role of E2F-1 in chemosensitivity to minor groove binding agents. British Journal of Cancer , 83 (Suppl) 65 - ?.

Harland, PC; Harland, SJ; (2000) John Charles Harland - Obituaries. BMJ (Clinical Research Ed.) , 320 (7242) 1149 - 1149.

Hartley, JA; Brooles, PJ; Mc Hugh, PJ; Clingen, PH; Gregson, SJ; Howard, PW; and Thurston, DE; (2000) SJG-136 (NSC-D694501)-A novel DNA sequence specific minor groove crosslinking agent with significant antitumor activity. PROC AM ASSOC CANCER RES , 41 2703 - ?.

Hooshmand-Rad, R; Hajkova, L; Klint, P; Karlsson, R; Vanhaesebroeck, B; Claesson-Welsh, L; Heldin, CH; (2000) The PI 3-kinase isoforms p110(alpha) and p110(beta) have differential roles in. Journal of Cell Science , 113 207 - 214.

Hooshmand-Rad, R; Hájková, L; Klint, P; Karlsson, R; Vanhaesebroeck, B; Claesson-Welsh, L; Heldin, CH; (2000) The PI 3-kinase isoforms p110(alpha) and p110(beta) have differential roles in PDGF- and insulin-mediated signaling. J Cell Sci , 113 Pt 2 207 - 214.

Hoskin, PJ; (2000) Palliative radiotherapy for disseminated disease. In: Greco, C and Zelefsky, MJ, (eds.) Radiotherapy of prostate cancer. (463 - 477). Harwood Academic Publishers: Amsterdam.

Hoskin, PJ; (2000) Bone metastases - radiotherapy. In: Rubens, RD and Mundy, GR and Martin, D, (eds.) Cancer and the skeleton. (159 - 170). : London.

Hoskin, PJ; Phillips, H; Jackson, S; Wims, P; Verma, N; Saunders, MI; (2000) Carbogen and nicotinamide with radical radiotherapy for bladder cancer: Updated Phase II results and launch of the BCON Phase III randomised trial. British Journal of Cancer , 83 84 - ?.

Hoskin, PJ; Vidler, K; (2000) Vaginal vault brachytherapy: the effect of varying bladder volumes on normal tissue dosimetry. British Journal of Radiology , 73 (872) 864 - 866.

Hughes, AN; Griffin, MJ; Newell, DR; Calvert, AH; Johnston, A; Kerr, B; ... Boddy, AV; + view all (2000) Clinical pharmacokinetic and in vitro combination studies of nolatrexed dihydrochloride (AG337, Thymitaq (TM)) and paclitaxel. BRIT J CANCER , 82 (9) 1519 - 1527.

J

Jankowska, PJ; Babb, P; Quinn, M; Whelan, JS; (2000) A population based study of the incidence and mortality for osteosarcoma in England and Wales. In: British Cancer Research Meeting, Brighton July 2000 Br J Cancer 2000;83 suppl 1:17.

Joiner, M; Short, S; Mayes, C; Lambin, P; Marples, B; Shah, N; Saunders, MI; (2000) Low dose hypersensitivity and induced radioresistance: Possibilities for therapy and implications for radioprotection. International Journal of Radiation Oncology Biology Physics , 46 (3) 692 - 692.

L

Leonard, P; Ledermann, JA; James, R; Hochhauser, D; Seymour, M; (2000) Phase II study of irinotecan and high dose infusional 5-FU and folinic acid (modified de Gramont) for first-line treatment of advanced or metastatic colorectal cancer. British Journal of Cancer , 83 44 - ?.

Lo, SK; Tolner, B; Rogers, G; Schapira, AHV; Hartley, JA; Hochhauser, D; (2000) Assessment of mitochondrial DNA damage by chemotherapeutic agents. British Journal of Cancer , 83 56 - ?.

M

McHugh, PJ; Hartley, JA; (2000) Defining the pathways involved in the initiation and resolution steps of DNA interstrand crosslink repair. British Journal of Cancer , 83 139 - ?.

McNeish, IA; Kanfer, EJ; Haynes, R; Agarwal, R; Harland, SJ; Newlands, ES; Seckl, MJ; (2000) Paclitaxel-containing high dose chemotherapy for relapsed or refractory germ cell tumours. British Journal of Cancer , 83 86 - ?.

Middleton, MR; Lee, SM; Aranc,; A,; Wood, M; Thatcher, N; Margison, GP; (2000) 06-methyguanine formation, repair protein depletion and clinical outcome with a 4 hr schedule of temozolomide in the treatment of advanced melanoma: results of a phase II study. International Journal of Cancer , 88 (3) 469 - 473.

Middleton, MR; Lorigan, P; Owens, J; Ashcroft, L; Lee, SM; Harper, P; Thatcher, N; (2000) A randomised phase III study comparing dacarbazine, BCNU, cisplatin and tamoxifen with dacarbazine and interferon in advanced melanoma. British Journal of Cancer , 82 (6) 1158 - 1162.

Middleton, MR; Ranson, M; Lee, SM; Bridgewater, J; McElhinney, RS; McMurry, TBH; ... Margison, GP; + view all (2000) Phase I study of 4-bromothenylguanine (4-BTG, PaTrin 2), an alkyltransferase inactivator, and temozolomide. In: (Proceedings) 11th NCI-EORTC-AACR Symposium on New Drugs in Cancer Therapy, Amsterdam.. (pp. 4574S - ?). Clinical Cancer Research

Mitjans, F; Piulats, J; Meyer, T; Marshall, JF; Fittschen, C; Goodman, S; ... Reyes, G; + view all (2000) In vivo therapy of malignant melanoma by means of antagonists of αv integrins. International Journal of Cancer , 87 (5) 716 - 723. 10.1002/1097-0215(20000901)87:5<716::AID-IJC14>3.0.CO;2-R.

O

Osborne, M; Glynne-Jones, A; Makris, A; (2000) Chemoradiation followed by immediate boost in squamous cell carcinoma of the anus. British Journal of Cancer , 83 71 - ?.

P

Patterson, LH; Paniwynk, Z; Pohrs, K; Teesdale-Spittle, PH; Hartley, JA; Plumb, J; (2000) A novel alkylating anthraquinone that is effective against resistant ovarian cancer cells. Proceedings of the American Association for Cancer Research , 41 2701 - ?.

Pedley, RB; Sharma, SK; Boxer, G; Flynn, AA; Boden, R; Watson, R; ... Begent, RHJ; + view all (2000) Tumour eradication by combined antibody-directed and antivascular therapy. British Journal of Cancer , 83 19 - ?.

Pedley, RB; Sharma, SK; Boxer, GM; Flynn, AA; Boden, R; Watson, R; ... R, HJ; + view all (2000) Tumour eradication by combined antibody-directed and antivascular therapy. In: (Proceedings) Proceedings BACR, Br J Cancer. (pp. 13 - ?).

Pedley, RB; Sharma, SK; Hill, SA; Boden, R; Boxer, GM; Flynn, AA; ... R, HJ; + view all (2000) Tumour ablation by combined antibody-directed and antivascular therapies. In: (Proceedings) Proceedings American Association for Cancer Research. (pp. 79 - ?).

Pettet, E; Phillips, H; Jackson, S; Saunders, MI; (2000) The time span between symptom onset and the start of radiotherapy in the treatment of head and neck tumours - A retrospective review. British Journal of Cancer , 83 78 - ?.

Pritchard, JK; Lewis, I; Whelan, JS; Hale, J; Pagonis, C; Durrant, LG; (2000) Immune response to the anti-idiotype cancer vaccine, 105AD7, following chemotherapy in osteosarcoma patients. In: SIOP, Amsterdam Oct 2000.

R

Raymond, EE; Fumoleau, P; Roche, H; Schellens, JHM; Dittrich, C; Punt, CJA; ... Ravic, M; + view all (2000) Combined results of 4 phase I and pharmacokinetic (PK) studies of E7070, a novel chloroindolyl-sulphonamide inhibiting the activation of cdk2 and cyclin E. Clinical Cancer Research , 6 315 - ?.

Rogers, S; Whelan, JS; (2000) Cerebral metastases from malignant fibrous histiocytoma of bone. Sarcoma , 4 125 - 128. Gold open access

Roos, DE; O'Brien, PC; Smith, JG; Spry, NA; Hoskin, PJ; Burmeister, BH; ... Bernshaw, DM; + view all (2000) A role for radiotherapy in neuropathic bone pain: Preliminary response rates from a prospective trial (Trans-Tasman Radiation Oncology Group, TROG 96.05). International Journal of Radiation Oncology Biology Physics , 46 (4) 975 - 981.

Rudd, RM; Gower, NH; James, LE; Gregory, W; Eisen, TQ; Lee, SM; et, A; (2000) A phase II/III randomised comparison of gemcitabine/carboplatin (GC) with mitomycin, ifosfamide and cisplatin (MIC) in advanced non-small cell lung cancer (NSCLC). In: (Proceedings) 9th World Conference on Lung Cancer, Tokyo, Japan.. (pp. 21 - ?). Lung Cancer

S

Saunders, MI; (2000) The implications and opportunities of the CHART trial in the treatment of non-small cell lung cancer. British Journal of Cancer , 83 S5 - ?.

Shah, N; Groom, N; Jackson, S; Sibtain, A; Hoskin, P; (2000) A pilot study to assess the feasibility of prior scalp cooling with palliative whole brain radiotherapy. British Journal of Radiology , 73 (869) 514 - 516.

Shah, N; Hoskin, P; McMillan, A; Gibson, P; Lowe, J; Wong, WL; (2000) The impact of FDG positron emission tomography imaging on the management of lymphomas. British Journal of Radiology , 73 (869) 482 - 487.

Shah, N; Hoskin, P; Sibtain, A; Baddeley, H; Taylor, J; Saunders, M; (2000) Blood oxygen level dependent (BOLD) MRI imaging: A non invasive assessment of hypoxia and perfusion in solid tumours. British Journal of Cancer , 83 15 - ?.

Shah, N; Saunders, M; Dische, S; (2000) A pilot study of postoperative CHART and CHARTWEL in head and neck cancer. British Journal of Cancer , 83 77 - ?.

Shamash, J; Lee, SM; Radford, JA; Rohatiner, AZS; Chang, J; Morgenstern, OR; ... Lister, TA; + view all (2000) Patterns of relapse and subsequent management following high dose chemotherapy with autologous haemopoietic support in relapsed or refractory Hodgkin's lymphoma. Annals of Oncology , 11 (6) 715 - 719.

Sharma, SK; Pedley, RB; Bhatia, J; Minton, N; Chester, KA; Begent, RHJ; (2000) In vivo characteristics of an engineered fusion protein for use in ADEPT. In: British Journal of Cancer. (pp. 172 - 172).

Sharma, SK; Pedley, RB; Bhatia, J; Minton, N; Chester, KA; Begent, RHJ; (2000) In vivo characteristics of an engineered fusion protein for use in ADEPT. British Journal of Cancer , 83 172 - ?.

Sharma, SK; Pedley, RB; Bhatia, J; Minton, N; Chester, KA; Begent, RHJ; (2000) In vivo characteristics of an engineered fusion protein for use in ADEPT. In: (Proceedings) British Journal of Cancer. (pp. 71 - 71).

Sharma, SK; Pedley, RB; Bhatia, J; Minton, N; Chester, KAAB; R, HJ; (2000) In vivo characteristics of a glycosylated fusion protein for prodrug activation. In: (Proceedings) Proceedings American Association for Cancer Research. (pp. 710 - ?).

Short, S; (2000) UNSPECIFIED In: (Proceedings) Radiobiology 2000, Trivandrum, India.

Short, S; C, B; M,; (2000) The treatment of malignant cerebral tumours. Hospital Medicine , 61 (11) 772 - 777.

Short, SC; Traish, D; Dowe, A; Hines, F; Brada, M; (2000) UNSPECIFIED In: (Proceedings) 4th Congress of the European Association for Neuro-Oncology.

Sibtain, A; Bradshaw, A; Shah, N; Hoskin, PJ; (2000) Late complications of mantle radiotherapy for Hodgkin's lymphoma. British Journal of Cancer , 83 223 - ?.

Sibtain, A; Hill, SA; Goodchild, KA; Shah, N; Saunders, MI; Hoskin, PJ; (2000) Modification of human tumour blood flow using pentoxifylline, nicotinamide and carbogen. British Journal of Cancer , 83 15 - ?.

Sibtain, A; Shah, N; Saunders, MI; Hoskin, PJ; (2000) Is there a relationship between pre-treatment haemoglobin and outcome in non-small cell lung cancer treated with radiotherapy? British Journal of Cancer , 83 58 - ?.

Smith, PG; Thomas, HD; Barlow, HC; Griffin, RJ; Golding, BT; Calvert, AH; ... Curtin, NJ; + view all (2000) In vitro activity and in vivo pharmacology of two novel nucleoside transport inhibitors, NU3108 and NU3121. Clinical Cancer Research , 6 445 - ?.

Spanswick, VJ; Craddock, C; Sekhar, M; Hartley, JA; (2000) Repair of DNA interstrand crosslinks as a mechanism clinical resistance to melphalan in multiple myeloma. British Journal of Cancer , 83 35 - ?.

Spanswick, VJ; Craddock, C; Sekhar, M; Hartley, JA; (2000) Repair of DNA interstrand crosslinks as a mechanism of clinical resistance to melphalan in multiple myeloma. British Journal of Cancer , 83 (Suppl) 35 - ?.

Spencer, DIR; Purdy, D; Minton, N; Whitelegg, NR; Rees, AR; Begent, RHJ; Chester, KA; (2000) Mutating ADEPT enzyme CPG2 to reduce its immunogenicity. British Journal of Cancer , 83 (Suppl) 171 - ?.

Strauss, S; McTiernan, A; Driver, D; Hall-Craggs, M; Sandison, A; Cassoni, A; ... Whelan, JS; + view all (2000) A single centre experience of an intensive induction therapy (VIDE) including stem cell collection for Ewing’s family of tumours (EFT). In: European Musculoskeletal Oncology Society Meeting, May 2000.

Strauss, S; McTiernan, A; Whelan, JS; (2000) Spontaneous regression of pulmonary metastases in three patients with bone and soft tissue sarcomas. In: Musculoskeletal Oncology Society Meeting, May 2000.

T

Tolner, B; Hartley, JA; Hochhauser, D; (2000) Modulation of topoisomerase II alpha expression at confluence by minor groove binders. British Journal of Cancer , 83 165 - ?.

Tolner, B; Hartley, JA; Hochhauser, D; (2000) Modulation of topoisomerase II alpha expression at confluence by minor groove binders. British Journal of Cancer , 83 165 - ?.

V

Verweij, J; Lee, SM; Ruka, W; Buesa, J; Coleman, R; van, HR; ... Judson, IR; + view all (2000) Randomised phase II study of docetaxel versus doxorubicin in first- and second-line chemotherapy for locally advanced or metastatic soft tissue sarcomas in adults: a study of the european organization for research and treatment of cancer soft tissue and bone sarcoma group. Journal of Clinical Oncology , 18 (10) 2081 - 2086.

W

Waibel, R; Stichelberger, R; Alberto, R; Schubiger, PA; Chester, KA; Begent, RHJ; (2000) Site-directed labelling of single chain antibodies with 99(m)technetium and (188)rhenium. In: European Journal Of Nuclear Medicine. (pp. 15 - 15).

Whelan, JS; (2000) Multidisciplinary care in a dedicated teenage cancer unit. In: Coping with Sarcoma, Berlin April 2000.

Whelan, JS; McTiernan, A; (2000) A Phase II study of docetaxel for the treatment of recurrent osteosarcoma and Ewing’s tumours. In: European Musculoskeletal Oncology Society Meeting, May 2000.

Whelan, JS; Weeden, S; Uscinska, B; McTiernan, A; (2000) Prolonged follow up of extremity osteosarcoma. Results from the European Osteosarcoma Intergroup. In: European Musculoskeletal Oncology Society Meeting, May 2000.

Whelan, JS; Weeden, S; Uscinska, B; McTiernan, AFTEOI; (2000) Localised extremity osteosarcoma: Mature survival data from two European Osteosarcoma Intergroup randomised clinical trials. In: New Orleans May 2000 Proc ASCO 2000;19: 552.

This list was generated on Sun Jan 25 08:19:11 2015 GMT.